AI therapeutics firm Deep Genomics is claiming a world first after using artificial intelligence to identify a therapeutic drug candidate. While many companies are using AI as a guide in the ...

Time permitting, I want to give thoughts on the future of AI research in genomics and how to make computational methods development more systematic and more accessible. Andrew Delong is Head of ...

Among the major classes of RNAs in the cell, tRNAs remain the most difficult to characterize via deep sequencing approaches, as tRNA structure and nucleotide modifications can each interfere with cDNA ...

The Core uses 15 separate microsatellite markers to differentiate human cell lines. When pricing a Next-Gen Sequencing project (aka Deep Sequencing) there are several factors that should be taken into ...

A Look into TXG's International Revenue Streams Of the total revenue, $12.73 million came from Asia Pacific (excluding China) during the last fiscal quarter, accounting for 9.0%. This represented ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on NeoGenomics (NASDAQ:NEO) in the last three months. The table below offers a condensed view ...

AI therapeutics firm Deep Genomics is claiming a world first after using artificial intelligence to identify a therapeutic drug candidate. While many companies are using AI as a guide in the ...